Dual-Antiplatelet Therapy After Drug-Eluting Stenting in ACS This systematic review and network meta-analysis investigates the optimal duration of dual antiplatelet therapy in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary interve...

3 mo of #DAPT followed by potent #P2Y12i monotherapy was ranked as the best option to reduce #MACCE. Because most patients receiving P2Y12i monotherapy were taking ticagrelor, the safety of stopping aspirin in those taking clopidogrel remains unclear #cardiosky #MACE
jamanetwork.com/journals/jam...